Altair Incorporated | |
4388 Leisure Time Dr, Diamondhead, Mississippi 39525 | |
(228) 222-4354 |
Name | Altair Incorporated |
---|---|
Organization Name | Altair Incorporated |
Location | 4388 Leisure Time Dr, Diamondhead, Mississippi 39525 |
Type | Supplier |
Phone | (228) 222-4354 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
In a speech delivered at the XIX International AIDS Conference in Washington, D.C., on Monday, U.S. Secretary of State Hillary Clinton "underscored the United States' commitment to achieving an 'AIDS-free generation' and announced more than $150 million in additional funding," Politico reports.
Akashi Therapeutics, Inc., announced today that the U.S. Food and Drug Administration has granted Fast Track designation to the company's most advanced product candidate, HT-100 (delayed-release halofuginone), an orally available, small molecule drug candidate intended to reduce fibrosis and inflammation and promote healthy muscle regeneration in boys with DMD.
Furiex Pharmaceuticals, Inc. today confirmed that Takeda Pharmaceutical Company Limited announced that its wholly-owned subsidiary, Takeda Global Research & Development Center, Inc. has resubmitted New Drug Applications (NDAs) to the U.S. Food and Drug Administration (FDA) for alogliptin and fixed-dose combination therapy alogliptin and pioglitazone for the treatment of type 2 diabetes in adults.
For decades, researchers have tried to understand why breast cancer in younger black women is such a significant public health problem.
› Verified 3 days ago
News Archive
In a speech delivered at the XIX International AIDS Conference in Washington, D.C., on Monday, U.S. Secretary of State Hillary Clinton "underscored the United States' commitment to achieving an 'AIDS-free generation' and announced more than $150 million in additional funding," Politico reports.
Akashi Therapeutics, Inc., announced today that the U.S. Food and Drug Administration has granted Fast Track designation to the company's most advanced product candidate, HT-100 (delayed-release halofuginone), an orally available, small molecule drug candidate intended to reduce fibrosis and inflammation and promote healthy muscle regeneration in boys with DMD.
Furiex Pharmaceuticals, Inc. today confirmed that Takeda Pharmaceutical Company Limited announced that its wholly-owned subsidiary, Takeda Global Research & Development Center, Inc. has resubmitted New Drug Applications (NDAs) to the U.S. Food and Drug Administration (FDA) for alogliptin and fixed-dose combination therapy alogliptin and pioglitazone for the treatment of type 2 diabetes in adults.
For decades, researchers have tried to understand why breast cancer in younger black women is such a significant public health problem.
› Verified 3 days ago
Cvs Pharmacy #10755 Type: Community/Retail Pharmacy Location: 4422 Kalani Dr, Diamondhead, Mississippi 39525 Phone: (228) 255-7343 | |
Altair Incorporated Type: Medicare Supplier Location: 4388 Leisure Time Dr, Diamondhead, Mississippi 39525 Phone: (228) 222-4354 |